Namaste Technologies (TSXV:N) announced its subsidiary signed a distribution agreement with BlueSky Biologicals agreeing to distribute the full-spectrum, hemp-derived cannabidiol (CBD) products in its UK and European marketplace.
As quoted in the press release:
The UK has classified CBD as a food supplement, as such, Namaste has been focused on building a carefully curated CBD supply chain for its UK platform. Namaste’s launch of CBD sales in the UK and EU are the first steps of the Company’s initiative to leverage its platform, technology and consumer databases to enter into cannabis consumable sales in the UK and EU.
In Canada, CBD is regulated under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) program, which restricts non-ACMPR vendors from selling it. CBD is a type of cannabinoid which is present in both cannabis and industrial hemp. Most CBD products outside of Canada are produced using industrial hemp, which is naturally high in CBD and low in delta-9 tetrahydrocannabinol (THC).
The UK’s recent classification of CBD opens the market to Namaste to leverage its site traffic and database to create a new high-growth revenue stream in its UK marketplace. BlueSky’s full spectrum products have been created to fill the unmet global demand for cannabinoids. Their products have unique formulations and are based on their proprietary Golden Harvest cannabinoid blend-. Additionally, BlueSky’s hemp is organically grown using sustainable farming practices, which is the foundation for their cannabinoid products containing no additives, chemicals, or preservatives.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).